<i>MGMT</i> promoter methylation determined by the MGMT-STP27 algorithm is not predictive for outcome to temozolomide in IDH-mutant anaplastic astrocytomas
C. Mircea S. Tesileanu, Thierry Gorlia, Vassilis Golfinopoulos, Pim J. French, Martin J. van den Bent
Topics & Concepts
TemozolomideMethylationO-6-methylguanine-DNA methyltransferaseAnaplastic astrocytomaMutantCancer researchMethyltransferaseMedicineOncologyGlioblastomaAstrocytomaBiologyGeneticsGeneGlioma Diagnosis and TreatmentBrain Metastases and TreatmentHistone Deacetylase Inhibitors Research